Shuttle Pharmaceuticals Holdings (SHPH) Cash & Current Investments (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Cash & Current Investments history runs 6 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 76.44% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 76.44% YoY), while the FY2025 annual figure was $257955.0, down 86.57% from the prior year.
• Cash & Current Investments was $1.1 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $257955.0 in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $9.1 million in Q3 2022 to a low of $156656.0 in Q3 2024.
• Historically, Cash & Current Investments has averaged $4.4 million across 5 years, with a median of $4.5 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments surged 6191.01% in 2022, then tumbled 97.7% in 2024.
• A 5-year view of Cash & Current Investments shows it stood at $5.4 million in 2022, then grew by 6.71% to $5.8 million in 2023, then sank by 66.75% to $1.9 million in 2024, then plunged by 86.57% to $257955.0 in 2025, then surged by 312.0% to $1.1 million in 2026.
• The last three Cash & Current Investments figures came in at $1.1 million (Q1 2026), $257955.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.